Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 12/31/15
Due: 12/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection | NCT02176135 | Vaccine and Gene Therapy Institute, Florida | user2@example.com | None | - | 2017-01-31 | 2018-01-31 | - | - | 2025-07-14 |
| Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection | NCT02017587 | Vaccine and Gene Therapy Institute, Florida | user2@example.com | None | 2013-12-31 | 2015-12-31 | 2016-12-31 | - | - | 2025-07-14 |